CGMs Reduce Health Care Costs, but Remain Under Prescribed

Use of continuous glucose monitors (CGMs) among individuals with diabetes treated with bolus insulin is associated with a nearly 20% reduction in total health care costs and a 23% decrease in acute care utilization over one year, according to a new study from CCS.